News
-
Barton Distributes $640,000 in JMEI Tax Credits
-
Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
-
Redwood AI Corp. Announces Engagement for IR Services
-
DigiPower X Announces Closing of Settlement
-
Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
-
AGTech to Help Build One-Stop Trading Services Platform as Hong Kong Gold Exchange Opens for the Year of the Horse
-
Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
-
Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
-
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
-
Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI